Yeungnam Univ J Med Search

CLOSE


Yeungnam Univ J Med > Volume 16(2); 1999 > Article
Yeungnam University Journal of Medicine 1999;16(2):155-168.
DOI: https://doi.org/10.12701/yujm.1999.16.2.155    Published online December 31, 1999.
Recent Advances in the Drug Therapy of Osteoporosis.
Hyoung Woo Lee
Department of Internal Medicine College of Medicine, Yeungnam University Taegu, Korea.
Abstract
Osteoporosis is one of the most important public health problems facing the aging population. Drug therapy for osteoporosis can be divided operationally into two main categories: drugs that inhibit bone resorption, and thus reduce bone turnover, and those that stimulate bone formation, exerting an anabolic effect. Antiresorptive agents such as estrogens, calcitonin, and bisphosphonates are most effective in the prevention of osteoporosis. Formation-stimulating agents such as sodium fluoride or monofluorophosphate, parathyroid hormone fragments, and anabolic steroids are of potential value in the treatment of established osteoporosis, where bone mass s already low and benefit from antiresorptive drug is likelyto be small. Recently, raloxifene, a selective estrogen receptor modulator, has become available in various countries for clinical use in the treatment of involutional osteoporsis . This paper will review the use of these drugs in postmenopausal woman.
Key Words: Osteoporosis, Antiresorptive agents, Formation-stimulating agents


ABOUT
ARTICLE CATEGORY

Browse all articles >

BROWSE ARTICLES
AUTHOR INFORMATION
Editorial Office
170 Hyeonchung-ro, Nam-gu, Daegu 42415, Korea
Tel: +82-53-640-6832    Fax: +82-53-651-0394    E-mail: yujm@yu.ac.kr                

Copyright © 2019 by Yeungnam University College of Medicine. All rights reserved.

Developed in M2community

Close layer
prev next